Literature DB >> 12825829

Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling.

Paul A Insel1, Rennolds S Ostrom.   

Abstract

1. As initially shown by Seamon and Daly, the diterpene forskolin directly activates adenylyl cyclase (AC) and raises cyclic AMP levels in a wide variety of cell types. In this review, we discuss several aspects of forskolin action that are often unappreciated. These include the utility of labeled forskolin as a means to quantitate the number of AC molecules; results of those types of studies, coupled with efforts to increase AC expression, document that such expression stoichiometrically limits cyclic AMP formation by hormones and neurotransmitters. 2. Response to forskolin is also strongly influenced by the activation of AC by the heterotrimeric G-protein, Gs. Gs-promoted enhancement of AC activity in response to forskolin occurs not only when cells are incubated with exogenously administered agonists that activate G-protein-coupled receptors but also by agonists that can be endogenously released by cells. 3. Such agonists, which include ATP and prostaglandins, serve as autocrine/paracrine regulators of cellular levels of cyclic AMP under "basal" conditions and also in response to forskolin and to agonists that promote release of such regulators. 4. The ability of forskolin to prominently activate cyclic AMP generation has proved valuable for understanding stoichiometry of the multiple components involved in "basal" cyclic AMP formation, in enzymologic studies of AC as well as in defining responses to cyclic AMP in cells within and outside the nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12825829     DOI: 10.1023/a:1023684503883

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  53 in total

1.  Photoaffinity labeling of adenylyl cyclase.

Authors:  Michael K Sievert; Gulhan Pilli; Yu Liu; Elizabeth M Sutkowski; Kenneth B Seamon; Arnold E Ruoho
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

2.  Interaction of forskolin with the P-glycoprotein multidrug transporter.

Authors:  D I Morris; L A Speicher; A E Ruoho; K D Tew; K B Seamon
Journal:  Biochemistry       Date:  1991-08-27       Impact factor: 3.162

3.  Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway.

Authors:  V O Rybin; X Xu; M P Lisanti; S F Steinberg
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

4.  Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes.

Authors:  M Gao; P Ping; S Post; P A Insel; R Tang; H K Hammond
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  [3H]forskolin. Direct photoaffinity labeling of the erythrocyte D-glucose transporter.

Authors:  M F Shanahan; D P Morris; B M Edwards
Journal:  J Biol Chem       Date:  1987-05-05       Impact factor: 5.157

6.  Alteration in Gs-mediated signal transduction in S49 lymphoma cells treated with inhibitors of microtubules.

Authors:  D Leiber; J R Jasper; A A Alousi; J Martin; D Bernstein; P A Insel
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

7.  Affinity labeling of forskolin-binding proteins. Comparison between glucose carrier and adenylate cyclase.

Authors:  E Pfeuffer; T Pfeuffer
Journal:  FEBS Lett       Date:  1989-05-08       Impact factor: 4.124

8.  Aluminum: a requirement for activation of the regulatory component of adenylate cyclase by fluoride.

Authors:  P C Sternweis; A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  [125I]-labeled forskolin analogs which discriminate adenylyl cyclase and a glucose transporter: pharmacological characterization and localization of binding sites in rat brain by in vitro receptor autoradiography.

Authors:  N M Appel; J D Robbins; E B De Souza; K B Seamon
Journal:  J Pharmacol Exp Ther       Date:  1992-12       Impact factor: 4.030

10.  Colchicine and cytochalasin B enhance cyclic AMP accumulation via postreceptor actions.

Authors:  J R Jasper; S R Post; K H Desai; P A Insel; D Bernstein
Journal:  J Pharmacol Exp Ther       Date:  1995-08       Impact factor: 4.030

View more
  95 in total

1.  Role of adenylyl cyclase activator in controlling experimental diabetic nephropathy in rats.

Authors:  Lakhwinder Singh; Surbhi Rana; Sidharth Mehan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-10-29

2.  Somatostatin coupling to adenylyl cyclase activity in the mouse retina.

Authors:  Barbara Pavan; Sara Fiorini; Massimo Dal Monte; Laura Lunghi; Carla Biondi; Paola Bagnoli; Davide Cervia
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-08-12       Impact factor: 3.000

3.  Quantification of hormone sensitive lipase phosphorylation and colocalization with lipid droplets in murine 3T3L1 and human subcutaneous adipocytes via automated digital microscopy and high-content analysis.

Authors:  Patrick M McDonough; Randall S Ingermanson; Patricia A Loy; Erick D Koon; Ross Whittaker; Casey A Laris; Jeffrey M Hilton; James B Nicoll; Benjamin M Buehrer; Jeffrey H Price
Journal:  Assay Drug Dev Technol       Date:  2010-12-27       Impact factor: 1.738

4.  TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder.

Authors:  Jeongmin Song; Brian L Bishop; Guojie Li; Matthew J Duncan; Soman N Abraham
Journal:  Cell Host Microbe       Date:  2007-06-14       Impact factor: 21.023

5.  Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation.

Authors:  Scoty M Hearst; Mariper E Lopez; Qingmei Shao; Yong Liu; Parminder J S Vig
Journal:  J Neurochem       Date:  2010-04-30       Impact factor: 5.372

Review 6.  Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies.

Authors:  Stephen J Hill; Christine Williams; Lauren T May
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

7.  Adrenergic pathway activation enhances brown adipose tissue metabolism: a [¹⁸F]FDG PET/CT study in mice.

Authors:  M Reza Mirbolooki; Sanjeev Kumar Upadhyay; Cristian C Constantinescu; Min-Liang Pan; Jogeshwar Mukherjee
Journal:  Nucl Med Biol       Date:  2013-10-01       Impact factor: 2.408

8.  cAMP/PKA-dependent increases in Ca Sparks, oscillations and SR Ca stores in retinal arteriolar myocytes after exposure to vasopressin.

Authors:  Owen Jeffries; Mary K McGahon; Peter Bankhead; Maria Manfredi Lozano; C Norman Scholfield; Tim M Curtis; J Graham McGeown
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-03       Impact factor: 4.799

9.  Forskolin Enhances Synaptic Transmission in Rat Dorsal Striatum through NMDA Receptors and PKA in Different Phases.

Authors:  Hyeong Seok Cho; Hyun Ho Lee; Se Joon Choi; Ki Jung Kim; Seung Hyun Jeun; Qing-Zhong Li; Ki-Wug Sung
Journal:  Korean J Physiol Pharmacol       Date:  2008-12-31       Impact factor: 2.016

10.  In vitro and in silico studies of 8(17),12E,14-labdatrien-18-oic acid in airways smooth muscle relaxation: new molecular insights about its mechanism of action.

Authors:  Edilson B Alencar Filho; Luciano A A Ribeiro; Thiego G C Carvalho; Fabrício S Silva; Luiz Antonio M S Duarte-Filho; Euzébio G Barbosa; Pedro M N Menezes; Josean F Tavares; Marcelo S da Silva; Bagnólia A Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-18       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.